A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
|2||Active, not recruiting||
PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.
Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery
† Study has passed its completion date and status has not been verified in more than two years.